Justin Mika

Justin Mika is an experienced executive in the biopharmaceutical field, currently serving as the Chief Executive Officer of AbTherx, a company focused on advancing therapeutic antibody discovery. Before this role, Justin was the Chief Executive Officer of AlivaMab Discovery Services and held senior leadership positions at Eurofins Discovery and Eurofins DiscoverX, where responsibilities included strategic direction and management of global operations. Justin is also a Board Member at PhenoVista Biosciences, contributing to the development of advanced phenotypic assay services. Academic credentials include a Bachelor of Science in Science with a focus on Biochemistry and Molecular Biology from Penn State University, a Master of Science in Organizational Development, and an MBA from the University of Delaware.